The influence of oral lipid loads on acylation stimulating protein (ASP) in healthy volunteers

International Journal of Obesity

Volumn 22, Issue 11, 1998, Pages 1096-1102

  Charlesworth, J A ^a,c   Peake, P W ^a   Campbell, L V ^b   Pussell, B A ^a   Grady, S O ^a   Tzilopoulos, T ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c PRINCE HENRY HOSPITAL   (Australia)

Author keywords

Acylation stimulating protein; Adipocyte; Complement; Lipid rich meal; Triacylglycerol; Volunteers

Indexed keywords

CHYLOMICRON; COMPLEMENT; POLYUNSATURATED FATTY ACID; PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACYLATION; ADIPOCYTE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT INTAKE; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNODIFFUSION; LIPID METABOLISM; MALE; NEPHELOMETRY; NORMAL HUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TIME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031788092     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800733     Document Type: Article

References (17)

1. Choy LN, Rosen BS, Spiegelman BM. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 1992; 267: 12736-12741.
2. Peake PW, O'Grady S, Pussell BA, Charlesworth JA. Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur J Clin Invest 1997; 27: 922-927.
3. Germinario R, Sniderman AD, Manuel S, Lefebvre SP, Baldo A, Cianflone K. Coordinate regulation of triacylglycerol synthesis and glucose transport by acylation-stimulating protein. Metabolism 1993; 42: 574-580.
4. Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991; 26: 495-499.
5. Cianflone K, Maslowska MH, Sniderman AD. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. J Clin Invest 1990; 85: 722-730.
6. Maslowska M, Scantlebury T, Germinario R, Cianflone K. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 1997; 38: 1-11.
7. Cianflone K, Vu H, Walsh M, Baldo A, Sniderman A. Metabolic response of acylation stimulating protein to an oral fat load. J Lipid Res 1989; 30: 1727-1733.
8. Sniderman AD, Cianflone K. The adipsin-ASP pathway and regulation of adipocyte function. Ann Med 1994; 26: 389-393.
9. Sniderman AD, Cianflone K. The adipsin-acylation-stimulating protein pathway and microenvironmental metabolic regulation. In: Simopoulos AP (ed). Genetic Variation and Dietary response. World Rev Nutr Diet. Karger: Basel, 1997; 80: 44-81.
10. Sniderman AD, Cianflone K, Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obes 1991; 15: 333-336.
11. Cianflone KM, Sniderman AD, Dallongeville J, Bertrand M, Raffal E, Davignon J. The relation between triglyceride synthesis in peripheral tissues and postprandial plasma tri-glyceride levels: preliminary evidence of a role for acylation stimulating protein. Clin Invest Med 1992; 15: 132-140.
12. Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum 1986; 29: 1085-1089.
13. Porcel JM, Ordi J, Castro-Salomo A, Vilardell M, Rodrigo MJ, Gene T, Warburton F, Kraus M, Vergani D. The value of complement activation products in the assessment of systemic lupus erythematosus flares. Clin Immunol Immunopathol 1995; 74: 283-288.
14. Chenoweth DE, Cheung AK, Henderson LW. Anaphylatoxin formation during hemodialysis: Effects of different dialyzer membranes. Kidney Int 1983; 24: 764-769.
15. Cianflone KD, Kalant E, Marliss EB, Gougeon R, Sniderman AD. Response of plasma ASP to a prolonged fast. Int J Obes 1995; 19: 604-609.
16. Charlesworth JA, Peake PW, Golding J, Mackie JD, Pussell BA, Timmerman V, Wakefield D. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus. Ann Rheum Dis 1989; 48: 153-159
17. Carbo N, Costelli P, Tessitore L, Bagby GJ, Lopez-Soriano FJ, Baccino FM, Argiles JM. Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model. Clin Sci 1994; 87: 349-355.